期刊
MOLECULAR PHARMACEUTICS
卷 16, 期 8, 页码 3430-3440出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.9b00209
关键词
PTX; CAP; PEG-Fmoc-CAP(2) prodrug micelles; breast cancer; combination chemotherapy
资金
- National Nature Science Foundation of China [81660590, 81803448]
- High Education Research Project of Ningxia [NGY2018-78]
- Ningxia Key Research and Invention Program of Science and Technology Cooperation of the East and the West [2017BY084]
- Third Batch of Ningxia Youth Talents Supporting Program [TJGC2018035]
Poor anticancer ability, serious adverse reaction, and drug resistance against paclitaxel (PTX) have limited its clinical applications. When a mouse breast carcinoma cell line (4T1) was treated with both PTX and capsaicin (CAP), there was a synergistic anti-proliferative effect demonstrated with a combination index of 0.28. Therefore, a novel polyethylene glycol-derivatized CAP (PEG-Fmoc-CAP(2)) polymeric prodrug micellar carrier was developed and further encapsulated with PTX for antitumor combination treatment. The PEG-Fmoc-CAP(2) polymeric micelles co-delivered with PTX achieved a 62.3% fraction of apoptotic cells in comparison to 45.4% fraction of apoptotic cells to that upon treatment with PTX alone. Comparable CAP amounts were found in the cell lysate treatment with PEG-Fmoc-CAP(2)-conjugated micelles to that of free CAP-treated 4T1 cells after 12 h treatment. Pharmacokinetic and biodistribution studies showed that the micelles possessed much longer circulation time in blood and preferential tumor tissue accumulation compared to the Taxol solution. Importantly, PTX/CAP-loaded micelles exhibited superior in vivo antitumor activity on the inhibition rate of tumor growth than other treatments (70.5% tumor growth reduction in PTX/CAP micelle-treated mice vs 57.8, 43.3, and 23.8% of tumor growth inhibition rate in PTX/PEG-Fmoc-OA(2) micelles, Taxol, and PEG-Fmoc-CAP(2) micelle-treated mice, respectively). Thus, the dual-functional PEG-Fmoc-CAP(2) polymeric prodrug micelles are a promising co-delivery nanosystem for achieving synergistic antitumor efficacy of PTX and CAP.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据